Viewing Study NCT06418685



Ignite Creation Date: 2024-05-19 @ 5:34 PM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06418685
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-17
First Post: 2024-01-30

Brief Title: Real-World Clinical Study on the Efficacy of Vibrating Capsule Vibrabot Capsule for Chronic Functional Constipation
Sponsor: Changhai Hospital
Organization: Changhai Hospital

Study Overview

Official Title: The First Affiliated Hospital of Naval Medical University
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: RWS-VC
Brief Summary: This study is a multi-center prospective cohort study which plans to include 300 patients with chronic functional constipation to treat with Vibrabot capsules and at the same time include 300 patients receiving constipation treatment during the same period

During the study it is necessary to collect the patients basic information baseline constipation status and treatment information capsule intake during treatment and concomitant medication During the treatment phase patients follow the doctors advice to receive Vibrabot capsule treatment and maintain stable dietary intake and exercise according to the constipation diagnosis and treatment guidelines

During the study patients need to scan the two-dimensional code or search for the electronic questionnaire Vibrabot Health Official Account on WeChat and fill in the relevant information during the treatment in the electronic questionnaire in a timely and truthful manner The treatment effect of the patients is evaluated by assessing the number of occurrences of spontaneous bowel movements SBM and complete spontaneous bowel movements CSBM
Detailed Description: Constipation is characterized by a decrease in bowel movements dry and hard stools and difficulty in defecation With changes in diet faster pace of life and social psychological factors the prevalence of chronic constipation is on the rise The global incidence of chronic constipation is 14 while the prevalence of chronic constipation in adults in China is 40 to 100 The prevalence of functional constipation in China is 6 The high-risk groups for constipation include the elderly women diabetics those taking opiates antipsychotic drugs or bedridden patients Occupation lifestyle dietary habits mental health family history of constipation and BMI are factors related to constipation

Constipation affects patients quality of life and some patients abuse laxatives or repeatedly seek medical treatment increasing medical costs The main treatments for constipation are adjusting lifestyle medication psychotherapy biofeedback and surgery However these methods often have side effects and patient satisfaction is still relatively low A new approach needs to be explored to address this clinical problem

The Disposable Gastrointestinal Vibrating Capsule System Vibrabot capsule NMPA Device Approval No 20223090282 is the worlds first approved and marketed product for treating constipation through purely physical means It can provide intermittent comfortable massages to the digestive tract activate the intestinal neural network awaken intestinal motility and help alleviate constipation issues Clinical study results show that the product is safe to use and can increase the frequency of bowel movements in patients with chronic functional constipation

This study focuses on post-marketing clinical study for patients with functional constipation of varying severity further evaluating the efficacy of the product in a large sample population

Through this real-world study to analyze the response of functional constipation patients with different severity treatment status capsule dosage and combined medication to Vibrabot capsule as well as the duration of efficacy maintenance during the follow-up period to compare the efficacy with patients treated with drugs or other therapies during the same period explore the possibility of curing functional constipation patients further improve the treatment satisfaction of constipation patients and promote the establishment and application of consensus or guidelines for the use of Vibrabot capsule in treating functional constipation

Each patient will undergo a series of study visits including screening treatment visit and follow-up visit The visit process is briefly described as follows

Visit 1 0 1 day - BaselineScreening Period

This visit includes

The patient will sign an informed consent form Set the inclusionexclusion criteria Guide patients to fill out the questionnaire using the Official Account and complete the Baseline Period Questionnaire in the Official Account

Prescription Vibrabot capsule treatment or other treatment options

Visit 2 Week 2 3 days - Treatment Period 1

This visit includes

Fill out the Daily Bowel Movement Questionnaire in the WeChat Official Account every day take Vibrabot capsules on time or opt for other treatment plans Fill out the Constipation Symptom Self-Assessment Scale and Assessment Scale for Quality of Life with Constipation in the Official Account every 2 treatment weeks

Record adverse events and concomitant treatments Prescription Vibrabot capsules or other treatment options Visit 3 Week 43 days - Treatment Period 2

This visit includes

Fill out the Daily Bowel Movement Questionnaire in the WeChat Official Account every day take Vibrabot capsules on time or opt for other treatment plans Fill out the Constipation Symptom Self-Assessment Scale and Assessment Scale for Quality of Life with Constipation in the Official Account every 2 treatment weeks

Record adverse events and concomitant treatments Prescription Vibrabot capsules or other treatment options Visit 4 Week 6 3 days - Treatment Period 3

This visit includes

Fill out the Daily Bowel Movement Questionnaire in the WeChat Official Account every day take Vibrabot capsules on time or opt for other treatment plans Fill out the Constipation Symptom Self-Assessment Scale and Assessment Scale for Quality of Life with Constipation in the Official Account every 2 treatment weeks

Record adverse events and concomitant treatments

Visit 5 Week 103 days - Follow-up Period

This visit includes

Fill out the Daily Bowel Movement Questionnaire in the WeChat Official Account every day Fill out the Constipation Symptom Self-Assessment Scale and Assessment Scale for Quality of Life with Constipation in the Official Account every 2 treatment weeks Record adverse events and concomitant treatments

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None